Loading...

Halo Collective Inc.

HALO.NENEO
Healthcare
Drug Manufacturers - Specialty & Generic
$19.90
$0.00(0.00%)
Canadian Market opens in 5h 25m

Halo Collective Inc. (HALO.NE) Stock Competitors & Peer Comparison

See (HALO.NE) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
HALO.NECA$19.90+0.00%205.2M-0.05-CA$362.87N/A
CURA.CNCA$5.22+9.21%4.1B-6.07-CA$0.86N/A
CURA.TOCA$4.73+6.29%3.7B-10.75-CA$0.44N/A
BHC.TOCA$7.70+2.53%2.9B-1.74-CA$4.43N/A
GTII.CNCA$11.11+4.91%2.6B16.83CA$0.66N/A
TRUL.CNCA$13.20+5.18%2.2B-16.71-CA$0.79N/A
VRNO.CNCA$6.32+6.76%2.2B-5.40-CA$1.17N/A
CRON.TOCA$3.60-0.83%1.4B-120.00-CA$0.03N/A
TLRY.TOCA$7.80-3.47%932.9M-0.39-CA$20.02N/A
TER.CNCA$2.38-0.42%804.8M-1.33-CA$1.79N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

HALO.NE vs CURA.CN Comparison May 2026

HALO.NE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, HALO.NE stands at 205.2M. In comparison, CURA.CN has a market cap of 4.1B. Regarding current trading prices, HALO.NE is priced at CA$19.90, while CURA.CN trades at CA$5.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

HALO.NE currently has a P/E ratio of -0.05, whereas CURA.CN's P/E ratio is -6.07. In terms of profitability, HALO.NE's ROE is -1.47%, compared to CURA.CN's ROE of -0.24%. Regarding short-term risk, HALO.NE is less volatile compared to CURA.CN. This indicates potentially lower risk in terms of short-term price fluctuations for HALO.NE.Check CURA.CN's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions